Geode Capital Management LLC Grows Stock Holdings in Eyenovia, Inc. (NASDAQ:EYEN)

Geode Capital Management LLC lifted its position in shares of Eyenovia, Inc. (NASDAQ:EYEN) by 36.6% during the third quarter, Holdings Channel reports. The institutional investor owned 557,994 shares of the company’s stock after purchasing an additional 149,471 shares during the period. Geode Capital Management LLC’s holdings in Eyenovia were worth $288,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. Point72 Asia Singapore Pte. Ltd. purchased a new stake in Eyenovia in the 2nd quarter worth $26,000. Financial Management Network Inc. purchased a new stake in Eyenovia in the 3rd quarter worth $39,000. Nations Financial Group Inc. IA ADV lifted its stake in Eyenovia by 78.6% in the 3rd quarter. Nations Financial Group Inc. IA ADV now owns 90,900 shares of the company’s stock worth $47,000 after purchasing an additional 40,000 shares in the last quarter. SkyView Investment Advisors LLC purchased a new stake in Eyenovia in the 2nd quarter worth $87,000. Finally, Armistice Capital LLC purchased a new stake in Eyenovia in the 2nd quarter worth $3,601,000. Hedge funds and other institutional investors own 25.84% of the company’s stock.

Analysts Set New Price Targets

Several analysts have commented on the stock. Brookline Capital Management reiterated a “hold” rating on shares of Eyenovia in a research note on Friday, November 15th. HC Wainwright cut shares of Eyenovia from a “buy” rating to a “neutral” rating and decreased their target price for the company from $12.00 to $2.00 in a research report on Monday, November 18th. William Blair restated a “market perform” rating on shares of Eyenovia in a research report on Friday, November 15th. Finally, LADENBURG THALM/SH SH restated a “neutral” rating on shares of Eyenovia in a research report on Monday, November 18th.

Eyenovia Stock Down 11.1 %

Shares of NASDAQ EYEN opened at $0.10 on Tuesday. The firm’s 50-day moving average price is $0.17 and its 200-day moving average price is $0.53. The company has a current ratio of 0.74, a quick ratio of 0.55 and a debt-to-equity ratio of 0.58. The stock has a market capitalization of $10.70 million, a price-to-earnings ratio of -0.13 and a beta of 1.31. Eyenovia, Inc. has a 12-month low of $0.08 and a 12-month high of $2.57.

Eyenovia (NASDAQ:EYEN) last issued its quarterly earnings results on Tuesday, November 12th. The company reported ($0.11) EPS for the quarter, beating the consensus estimate of ($0.13) by $0.02. Eyenovia had a negative net margin of 114,639.41% and a negative return on equity of 1,108.24%. During the same quarter in the prior year, the business posted ($0.18) EPS. On average, equities research analysts anticipate that Eyenovia, Inc. will post -0.49 EPS for the current fiscal year.

Eyenovia Company Profile

Eyenovia, Inc, an ophthalmic technology company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis.